Government: Page 76


  • Image attribution tooltip
    Fotolia
    Image attribution tooltip

    Advocate Aurora Health's new investment unit is on the hunt for deals

    The Midwestern giant joins other nonprofits in launching a for-profit unit to diversify its revenue streams. Some critics question whether the strategy fits with the mission and perks enjoyed by not-for-profit entities.

    By April 19, 2021
  • The Capitol building on a rainy D.C. day
    Image attribution tooltip
    E.A. Crunden/Healthcare Dive
    Image attribution tooltip

    HHS nominees get smooth confirmation hearing

    The scene was a contrast to the sometimes heated questioning of HHS Secretary Xavier Becerra, who was eventually confirmed by a narrow margin.

    By April 16, 2021
  • Trendline

    Surprise Billing

    Federal legislation banning surprise bills has hit a barrage of roadblocks, complicating efforts to protect consumers from unexpected out-of-network charges.

    By Healthcare Dive staff
  • Johnson & Johnson vaccine vials against the COVID-19 coronavirus are seen at the Klerksdorp Hospital as South Africa proceeds with its inoculation campaign on February 18, 2021
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    The US paused use of J&J's vaccine. What happens next?

    A call by regulators to stop J&J vaccinations won't dramatically disrupt supply in the U.S. But changes in labeling are possible, as is a renewed debate over vaccine hesitancy.

    By Ned Pagliarulo , Ben Fidler , Jonathan Gardner • April 14, 2021
  • Image attribution tooltip
    Jon Cherry via Getty Images
    Image attribution tooltip

    CDC panel delays decision on J&J vaccine, extending pause over rare side effect

    Advisers to the agency agreed to wait for more data before recommending new guidance, but aim to reconvene quickly to decide whether J&J vaccinations should be resumed, and for whom.

    By Jonathan Gardner • April 14, 2021
  • Medicare sequester cut pause extended through 2021

    The 2% cuts were first put on hold more than a year ago through federal coronavirus relief legislation. To pay for the extension, the new bill states the cuts will increase in 2030.

    By Hailey Mensik • April 14, 2021
  • Image attribution tooltip
    Adeline Kon/Healthcare Dive
    Image attribution tooltip

    Lawmakers urge HHS to conduct 'vigorous oversight' of hospital price posts after reports of noncompliance

    Hospitals are now required to publicly post the prices they negotiate with insurers online, but noncompliance is common. A bipartisan group from the House voiced their discontent in a letter to HHS Secretary Xavier Becerra.

    By April 14, 2021
  • Surprise Billing

    Patients hit with surprise medical bills paid ER docs 10 times more than others

    The findings published in Health Affairs suggest why some ER groups resist coming in-network with insurers: They stand to collect more in revenue if they stay outside a network, posing a financial risk to patients.

    By April 13, 2021
  • A still of COVID-19 vaccine vials from Johnson & Johnson going through production
    Image attribution tooltip
    Permission granted by Johnson & Johnson
    Image attribution tooltip

    US calls for pause in J&J coronavirus vaccine rollout after rare blood clotting cases

    The FDA and CDC recommended halting vaccinations while they investigate six cases of unusual blood clots in women given the company's shot.

    By Ben Fidler , Ned Pagliarulo • Updated April 13, 2021
  • AstraZeneca technicians work on manufacturing a vaccine
    Image attribution tooltip
    Courtesy of AstraZeneca
    Image attribution tooltip

    Researchers lay out hypothesis for rare side effect linked to AstraZeneca vaccine

    EU regulators have reiterated the benefits of the shot outweigh the risks, but the safety concerns are another hurdle to the vaccine's rollout in Europe. 

    By Ned Pagliarulo , Ben Fidler • April 9, 2021
  • Medtech industry, surgeons push Medicare to pull back prior authorization rules

    The medtech lobby joined 39 stakeholders in warning CMS that including cervical fusion with disc removal and implanted spinal neurostimulators as new service categories will delay patient access to medically necessary procedures.

    By Greg Slabodkin • April 8, 2021
  • An AstraZeneca scientists involved in vaccine research
    Image attribution tooltip
    Courtesy of AstraZeneca
    Image attribution tooltip

    AstraZeneca's coronavirus vaccine possibly linked to rare blood clots, EMA says

    Europe's drug regulator affirmed the benefits of vaccination outweigh the risks, but recommended the shot's label be updated to warn of the newly established side effect.

    By Ben Fidler • Updated April 7, 2021
  • Urgent care centers draw some ER visits but associated with higher spending overall

    The findings published in Health Affairs may suggest patients are going to the centers instead of more appropriate and lower cost settings like a primary care office or virtual visit.

    By April 7, 2021
  • Image attribution tooltip
    Getty
    Image attribution tooltip

    Nonprofit hospitals spent less on charity care than for-profit, government facilities: Health Affairs

    The research is likely to garner attention as skeptics have questioned whether nonprofit organizations dole out enough charity care to justify the tax breaks they receive.

    By April 6, 2021
  • Black patients far more likely to experience discrimination when seeking care: study

    Reports of discrimination based on race, ethnicity, disability, gender, sexual orientation or health condition were even higher for low-income Black adults and Black women, according to a new study by the Urban Institute.

    By Ron Shinkman • April 5, 2021
  • The FDA logo on a glass pane at the agency's campus in Silver Spring, Maryland.
    Image attribution tooltip
    Jacob Bell/Healthcare Dive
    Image attribution tooltip

    FDA warns of patient deaths tied to reusable urological endoscopes

    The agency is sounding the alarm after receiving more than 450 adverse event reports in four years tying patient infections to the devices, as it continues to track contamination issues in duodenoscopes.

    By Susan Kelly • Updated April 5, 2021
  • Shifting payer mix puts 340B hospitals at risk of losing eligibility

    AHA wants HHS to waive certain eligibility requirements to allow continued access to the program during the public health emergency, the group wrote in a letter to Secretary Xavier Becerra.

    By Hailey Mensik • April 1, 2021
  • Healthcare Doctor One year into COVID-19 crisis
    Image attribution tooltip
    Adeline Kon/Healthcare Dive
    Image attribution tooltip

    A year into the pandemic, advanced cancer diagnoses are rising

    Research from radiation oncologists and molecular pathologists add to evidence showing that many people skipped getting cancer screenings in 2020 as they avoided going to the doctor to minimize the risk of COVID-19 infection.

    By Susan Kelly • March 31, 2021
  • FTC challenges Illumina-Grail deal, putting $7B merger in jeopardy

    The commission said the union will "harm competition in the U.S. market for life-saving multi-cancer early detection tests." Illumina is opposing the action, but Wall Street analysts see no “easy fixes."

    By Nick Paul Taylor • March 31, 2021
  • The Joel Soloman Federal Building and Courthouse in Chattanooga
    Image attribution tooltip
    The image by Original image from Carol M. Highsmith’s America, Library of Congress collection is licensed under CC BY 2.0
    Image attribution tooltip

    Medical liability insurance premiums rising after stable decade, AMA report finds

    While providers grapple with the pandemic's toll on finances, some can face liability premiums of $200,000 a year, according to the analysis sponsored by the doctors' lobby.

    By Hailey Mensik • March 30, 2021
  • Exterior sign of Bristol-Myers Squibb
    Image attribution tooltip
    Permission granted by Bristol-Myers Squibb
    Image attribution tooltip

    FDA approves first CAR-T cell therapy for multiple myeloma

    Approval of Bristol Myers Squibb and Bluebird bio's Abecma expands use of CAR-T treatment beyond leukemia and lymphoma.

    By Ned Pagliarulo • March 29, 2021
  • Senate passes bill extending Medicare sequester cut pause

    CMS instructed Medicare administrative contractors to hold all claims on or after April 1, when the pause on cuts is scheduled to end. The House is expected to take up the Senate-passed bill when it returns the week of April 13.

    By Hailey Mensik • Updated March 31, 2021
  • A picture of the exterior of the US Department of Health and Human Services. In front of the building is a black sign designating the building's name.
    Image attribution tooltip
    Alex Wong via Getty Images
    Image attribution tooltip

    Hospitals flailed amid COVID-19 crisis, are unsure of future, OIG says

    Executives said they were worried about their workers experiencing trauma and concerned a shrinking recruitment pool for nurses could exacerbate staffing shortages.

    By Ron Shinkman • March 25, 2021
  • An illustration of an adenovirus
    Image attribution tooltip
    Courtesy of AstraZeneca
    Image attribution tooltip

    AstraZeneca, under fire, tries to repair image with new vaccine data

    Updated results show the vaccine is only slightly less effective than AstraZeneca originally reported. But the drugmaker's unusual break with a study committee may have damaged perception of the shot.

    By Ben Fidler • March 25, 2021
  • Capitol Hill in Washington, D.C.
    Image attribution tooltip
    Permission granted by E.A. Crunden
    Image attribution tooltip

    As Medicare sequester cut extension deadline looms, AHA urges Senate to act

    Without action, the 2% payment cuts to providers are slated to go back into effect April 1. The hospital lobby expects a vote this week.

    By Hailey Mensik • March 24, 2021
  • Image attribution tooltip
    Lydia Polimeni, National Institutes of Health
    Image attribution tooltip

    AstraZeneca may have used 'outdated' data to describe vaccine's efficacy, NIH says

    The British drugmaker said it will release updated data from the large U.S. trial within 48 hours, but the puzzling episode is another communication misstep for the company.

    By Ned Pagliarulo • March 23, 2021